Allergan Plc (AGN) 326.98 $AGN Business Highlights By

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Plc (AGN) 326.98 $AGN

Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 326.98 (+18.77), QSR: 41.50 (+1.41), F: 14.55 (+0.16), QSR.TO: 54.21 (+2.01), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), MHFI: 99.59 (-5.99)

Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
GlobeNewswire - Mon Jul 27, 4:45PM CDT
Allergan plc (NYSE:AGN) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Allergan's pending acquisition of KYTHERA.
AGN: 326.98 (+18.77), KYTH: 74.35 (+0.18)

Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.25 (+0.04), AGN: 326.98 (+18.77), AKRX: 46.16 (+0.77), SGNT: 25.48 (+0.22), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Stocks Fall For Fifth Straight Session On China Woes
at Investor's Business Daily - Mon Jul 27, 3:39PM CDT
Stocks fell for the fifth straight session Monday as a sell-off in China's main index sparked fears of a slowdown in the world's second-biggest economy. The Nasdaq fell 1%, sliding below its 50-day moving average. The Dow Jones industrial average...
AGN: 326.98 (+18.77), NFX: 30.88 (-1.90), CYBR: 59.83 (-3.18), SOHU: 42.74 (-1.94), TEVA: 72.00 (+10.15), MRO: 20.69 (-0.72), JD: 32.15 (-2.49), PAYC: 31.60 (-2.15), BABA: 81.40 (-1.62)

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 326.98 (+18.77), BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), TEVA: 72.00 (+10.15), TWTR: 34.70 (-0.72)

Stocks Down in the Dumps as Chinese Market Slumps
at The Street - Mon Jul 27, 3:05PM CDT
Wall Street sees no fresh start to the week as stocks suffer their fifth day of losses on Monday.
KMI: 35.22 (+0.37), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)

Stocks Extend Losing Streak as Oil Closes Below $48
at The Street - Mon Jul 27, 2:12PM CDT
Stocks spend their fifth day in the red on Monday, their longest longest streak in six months.
KMI: 35.22 (+0.37), DAL: 43.93 (-0.17), CEA: 44.34 (-3.08), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)

Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)

3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces
at Investor's Business Daily - Mon Jul 27, 12:37PM CDT
Stocks were back near session lows in early afternoon trading Monday, weighed down by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Nasdaq lost 0.9%, the Dow Jones industrial average gave up 0.7% and the S&P 500...
AGN: 326.98 (+18.77), BIDU: 197.68 (-8.57), BOOT: 31.44 (+0.61), TEVA: 72.00 (+10.15), BA: 141.03 (-3.03)

Cramer's Charitable Trust: We Love This Possible Allergan Deal
at The Street - Mon Jul 27, 11:30AM CDT
And we are raising our price target on AGN.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)

Stocks In The Red But Off Lows As Shanghai, Europe Weigh
at Investor's Business Daily - Mon Jul 27, 10:57AM CDT
U.S. stocks were under pressure near midday Monday, brought on by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Dow Jones industrial average and Nasdaq lost 0.8% while the S&P 500 shed 0.5%. Volume on both main...
BID: 41.23 (-0.53), VR: 45.29 (-0.21), ENTA: 47.47 (+2.28), AGN: 326.98 (+18.77), LOGM: 73.17 (+0.96), FFIV: 127.81 (+0.32), TEVA: 72.00 (+10.15), WAB: 97.93 (+6.59), X: 16.80 (+0.55)

Teva Pharmaceutical to Buy Allergan's Generics Unit in $40.5 Billion Deal - Stocks in the News
Madeleine Johnson - Zacks Investment Research - Mon Jul 27, 10:53AM CDT
Teva Pharmaceutical Industries has agreed to acquire Allergan Plc’s generic drug sector for roughly $40.5 billion.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)

Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China
PR Newswire - Mon Jul 27, 10:04AM CDT
Bloomage BioTechnology Corporation Limited ("Bloomage" or "The Company", Stock Code: 00963.HK) announces a strategic cooperation with the South Korean BioTech Company Medytox Inc. ("Medytox", Stock Code: 086900.KS) to establish a joint venture Medybloom to develop and promote Type A Botulinum Toxin ("Botulinum Toxin" business in China.
AGN: 326.98 (+18.77)

Stocks Remain in Red After Chinese Market Slump
at The Street - Mon Jul 27, 9:37AM CDT
Stocks trade lower Monday morning in response to a massive, inexplicable selloff in Chinese equities.
AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), BBY: 32.06 (-0.40), TEVA: 72.00 (+10.15), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), MHFI: 99.59 (-5.99), AAPL: 122.77 (-1.73)

Allergan (AGN) Stock Rises After $40.5 Billion Generic Drug Business Sale
at The Street - Mon Jul 27, 9:10AM CDT
Allergan (AGN) shares are climbing after the company sold its generic drug business to Teva for $40.5 billion today.
AGN: 326.98 (+18.77)

Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 326.98 (+18.77), PRGO: 193.60 (+7.10), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Latest Innovations in Healthcare You Shouldn't Miss Now

Updated Category News Views 138

Weekly Overview of Key Developments in Healthcare This past week marked a multitude of noteworthy events in the healthcare sector that deserve attention. With the ever-evolving landscape of medical advancements, it can be challenging to stay updated. Here’s an insightful recap of some major stories that emerged, ensuring you are well-informed about recent innovations....

Continue Reading
Aptiv Announces Financial Results Release and Investor Call Details

Updated Category News Views 168

Aptiv to Unveil Fourth Quarter Financial Performance Aptiv PLC (NYSE: APTV) is set to announce its financial results for the fourth quarter of 2024 on February 6, 2025. This much-anticipated event will provide insights into the company's performance over the past quarter and will be followed by an investor call that same day at 8:00 a.m. Eastern Standard Time. Investor...

Continue Reading
Nippon Express Europe Partners with Ukrainian Logistics Provider

Updated Category News Views 151

Nippon Express Europe and Formag Cooperation Agreement Nippon Express Europe GmbH, known as NX Europe, has recently agreed to collaborate with the Ukrainian logistics provider Formag-Kiev. This partnership aims to enhance the logistical support necessary for Ukraine's reconstruction efforts. The agreement is vital as it aligns with a broader vision to bolster Ukraine's...

Continue Reading
Trident Resources Corp. Elevates Mineral Resource Estimates Significantly

Updated Category News Views 168

Significant Update from Trident Resources Corp. Trident Resources Corp. is excited to share the latest updates regarding its mineral resource estimates for four gold deposits situated within the renowned La Ronge Gold Belt. With remarkable progress achieved, the company has witnessed a substantial 18% increase in indicated gold ounces totaling 896,500 and an astonishing...

Continue Reading
DouYu International Holdings Reports Q2 2024 Performance Insights

Updated Category News Views 85

DouYu International Holdings Limited Shares Financial Results DouYu International Holdings Limited (NASDAQ: DOYU) has announced its unaudited financial results for the latest quarter. As a prominent player in the game-focused live streaming industry, DouYu continues to adapt to the changing economic landscape and market dynamics. Financial Highlights for Q2 2024 In the...

Continue Reading